<ul>
<li>MarketBeat 周报 – 11/24 - 11/28</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，礼来公司、艾伯维和 PTC Therapeutics 是今天值得关注的三只制药股票。制药股票是指公开交易的公司股票，这些公司研究、开发、生产和销售处方药及相关疗法，包括传统药品制造商和许多生物技术公司。投资者将其视为潜在的高回报但高风险，因为估值依赖于临床试验结果、监管批准、专利保护和漫长的开发时间，导致事件驱动的波动性。这些公司在过去几天内的制药股票中交易量最高。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<h2>礼来公司 (LLY)</h2>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
<ul>
<li>一种万亿美金的药丸：礼来打破了医疗保健的天花板</li>
</ul>
<p>阅读我们关于 LLY 的最新研究报告</p>
<h2>艾伯维 (ABBV)</h2>
<p>艾伯维公司在全球范围内发现、开发、生产和销售药物。该公司提供 Humira，用于自身免疫性和肠道贝赫切特病以及脓皮病；Skyrizi 用于治疗中度至重度斑块型银屑病、银屑病性疾病和克罗恩病；Rinvoq 用于治疗类风湿性关节炎和银屑病性关节炎、强直性脊柱炎、特应性皮炎、轴性脊柱关节病、溃疡性结肠炎和克罗恩病；Imbruvica 用于治疗成人血癌；Epkinly 用于治疗淋巴瘤；Elahere 用于治疗癌症；Venclexta/Venclyxto 用于治疗血癌。</p>
<ul>
<li>一项宏伟的人工智能投资？斯坦利·德鲁肯米勒的最新科技动态</li>
</ul>
<p>阅读我们关于 ABBV 的最新研究报告</p>
<h2>PTC Therapeutics (PTCT)</h2>
<p>PTC Therapeutics, Inc. 是一家生物制药公司，专注于发现、开发和商业化用于治疗美国及国际上罕见疾病患者的药物。该公司提供 Translarna 和 Emflaza 用于治疗杜氏肌营养不良症；Upstaza 用于治疗芳香族 L-氨基酸脱羧酶 (AADC) 缺乏症，这是一种中枢神经系统疾病；Tegsedi 和 Waylivra 用于治疗罕见疾病；Evrysdi 用于治疗成人和儿童的脊髓性肌萎缩症 (SMA)。</p>
<p>阅读我们关于 PTCT 的最新研究报告</p>
<h2>精选文章</h2>
<ul>
<li>MarketBeat 十大股票推荐（2025 年 11 月）</li>
<li>CrowdStrike 在近期回调后准备反弹吗？</li>
<li>SanDisk 加入 S&amp;P 500：指数效应的内部分析</li>
<li>亚马逊进入修正区——是时候恐慌，还是加仓？</li>
<li>特斯拉被称为 “必买” 股票——原因在这里</li>
<li>为什么黄金和特朗普一样热爱黄金</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在你考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

PTCT

艾伯维

<p>礼来公司、艾伯维和 PTC Therap 被 MarketBeat 的股票筛选工具列为今天值得关注的顶级制药股票。这些公司的交易量最近最高。礼来专注于糖尿病和肥胖症治疗，艾伯维专注于自身免疫和癌症疗法，而 PTC Therap 则专注于罕见疾病。由于临床试验和监管批准等因素，制药股票属于高风险、高回报的投资</p>

<ul>
<li>MarketBeat Week in Review – 11/24 - 11/28</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周报 – 11/24 - 11/28</li>
</ul>
</div><p>Eli Lilly and Company, AbbVie, and PTC Therapeutics are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and sell prescription medicines and related therapies, including traditional drugmakers and many biotech firms. Investors view them as potentially high-reward but high-risk because valuations hinge on clinical trial results, regulatory approvals, patent protection, and long development timelines, leading to event-driven volatility. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，礼来公司、艾伯维和 PTC Therapeutics 是今天值得关注的三只制药股票。制药股票是指公开交易的公司股票，这些公司研究、开发、生产和销售处方药及相关疗法，包括传统药品制造商和许多生物技术公司。投资者将其视为潜在的高回报但高风险，因为估值依赖于临床试验结果、监管批准、专利保护和漫长的开发时间，导致事件驱动的波动性。这些公司在过去几天内的制药股票中交易量最高。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><h2>Eli Lilly and Company (LLY)</h2>
<div class="lb-trans"><h2>礼来公司 (LLY)</h2>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
</div><ul>
<li>A Trillion-Dollar Pill: Eli Lilly Broke the Healthcare Ceiling</li>
</ul>
<div class="lb-trans"><ul>
<li>一种万亿美金的药丸：礼来打破了医疗保健的天花板</li>
</ul>
</div><p>Read Our Latest Research Report on LLY</p>
<div class="lb-trans"><p>阅读我们关于 LLY 的最新研究报告</p>
</div><h2>AbbVie (ABBV)</h2>
<div class="lb-trans"><h2>艾伯维 (ABBV)</h2>
</div><p>AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.</p>
<div class="lb-trans"><p>艾伯维公司在全球范围内发现、开发、生产和销售药物。该公司提供 Humira，用于自身免疫性和肠道贝赫切特病以及脓皮病；Skyrizi 用于治疗中度至重度斑块型银屑病、银屑病性疾病和克罗恩病；Rinvoq 用于治疗类风湿性关节炎和银屑病性关节炎、强直性脊柱炎、特应性皮炎、轴性脊柱关节病、溃疡性结肠炎和克罗恩病；Imbruvica 用于治疗成人血癌；Epkinly 用于治疗淋巴瘤；Elahere 用于治疗癌症；Venclexta/Venclyxto 用于治疗血癌。</p>
</div><ul>
<li>A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves</li>
</ul>
<div class="lb-trans"><ul>
<li>一项宏伟的人工智能投资？斯坦利·德鲁肯米勒的最新科技动态</li>
</ul>
</div><p>Read Our Latest Research Report on ABBV</p>
<div class="lb-trans"><p>阅读我们关于 ABBV 的最新研究报告</p>
</div><h2>PTC Therapeutics (PTCT)</h2>
<div class="lb-trans"><h2>PTC Therapeutics (PTCT)</h2>
</div><p>PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children.</p>
<div class="lb-trans"><p>PTC Therapeutics, Inc. 是一家生物制药公司，专注于发现、开发和商业化用于治疗美国及国际上罕见疾病患者的药物。该公司提供 Translarna 和 Emflaza 用于治疗杜氏肌营养不良症；Upstaza 用于治疗芳香族 L-氨基酸脱羧酶 (AADC) 缺乏症，这是一种中枢神经系统疾病；Tegsedi 和 Waylivra 用于治疗罕见疾病；Evrysdi 用于治疗成人和儿童的脊髓性肌萎缩症 (SMA)。</p>
</div><p>Read Our Latest Research Report on PTCT</p>
<div class="lb-trans"><p>阅读我们关于 PTCT 的最新研究报告</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in November 2025</li>
<li>Is CrowdStrike Ready to Rally After Its Recent Pullback?</li>
<li>SanDisk Joins the S&amp;P 500: Inside the Index Effect Rally</li>
<li>Amazon Enters Correction Zone—Time to Panic, or to Load Up?</li>
<li>Tesla Just Got Called a “Must Own” Stock—Here’s Why</li>
<li>Why Gold Loves Trump as Much as Trump Loves Gold</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 十大股票推荐（2025 年 11 月）</li>
<li>CrowdStrike 在近期回调后准备反弹吗？</li>
<li>SanDisk 加入 S&amp;P 500：指数效应的内部分析</li>
<li>亚马逊进入修正区——是时候恐慌，还是加仓？</li>
<li>特斯拉被称为 “必买” 股票——原因在这里</li>
<li>为什么黄金和特朗普一样热爱黄金</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

11 月 27 日值得关注的制药类股票